Development of non-steroidal anti-inflammatory drug (NSAID) analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: Potential antineoplastic agents that work independently of cyclooxygenase isozymes*

David R Bauman; Steven Rudnick; Lawrence M Szewczuk; Yi Jin; Sridhar Gopishetty; Trevor M. Penning

doi:10.1124/mol.104.006569

OtherArticle

Development of non-steroidal anti-inflammatory drug (NSAID) analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: Potential antineoplastic agents that work independently of cyclooxygenase isozymes*

David R Bauman, Steven Rudnick, Lawrence M Szewczuk, Yi Jin, Sridhar Gopishetty and Trevor M. Penning

Molecular Pharmacology October 8, 2004, DOI: https://doi.org/10.1124/mol.104.006569

David R Bauman

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Steven Rudnick

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lawrence M Szewczuk

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yi Jin

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sridhar Gopishetty

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Trevor M. Penning

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
eLetters
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

In this issue

Molecular Pharmacology

Vol. 103, Issue 6

1 Jun 2023

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Editorial Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Development of non-steroidal anti-inflammatory drug (NSAID) analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: Potential antineoplastic agents that work independently of cyclooxygenase isozymes*

Message Subject (Your Name) has forwarded a page to you from Molecular Pharmacology

Message Body (Your Name) thought you would be interested in this article in Molecular Pharmacology.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

OtherArticle

Development of non-steroidal anti-inflammatory drug (NSAID) analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: Potential antineoplastic agents that work independently of cyclooxygenase isozymes*

David R Bauman, Steven Rudnick, Lawrence M Szewczuk, Yi Jin, Sridhar Gopishetty and Trevor M. Penning

Molecular Pharmacology October 8, 2004, DOI: https://doi.org/10.1124/mol.104.006569

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

OtherArticle

Development of non-steroidal anti-inflammatory drug (NSAID) analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: Potential antineoplastic agents that work independently of cyclooxygenase isozymes*

David R Bauman, Steven Rudnick, Lawrence M Szewczuk, Yi Jin, Sridhar Gopishetty and Trevor M. Penning

Molecular Pharmacology October 8, 2004, DOI: https://doi.org/10.1124/mol.104.006569

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Info & Metrics
eLetters
PDF

Main menu

User menu

Search

Development of non-steroidal anti-inflammatory drug (NSAID) analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: Potential antineoplastic agents that work independently of cyclooxygenase isozymes*

In this issue

Development of non-steroidal anti-inflammatory drug (NSAID) analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: Potential antineoplastic agents that work independently of cyclooxygenase isozymes*

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

More Information

ASPET's Other Journals